Mona Sabra is an Endocrinology/Metabolic physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 56 publications with 2,940 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 100656007
Telephone
646-888-3270Registry record last updated 7 Sept 2010.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
95.9%l-Thyroxine89.9%Levothyroxine Sodium66%Synthroid32%Tirosint3%Part D<11 patientsl-Triiodothyronine2.5%Liothyronine Sodium100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.9%Vitamin D3 Analog2.9%Calcitriol100%Part D≥11 patientsSensory organs
1.3%Corticosteroid1.3%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer
The Journal of Clinical Endocrinology & Metabolism
2026 - Phase 2 of trametinib plus radioiodine in <i>RAS-</i>mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).
Journal of Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”